Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Artificial Life, Inc. is a technology company that specialized in artificial intelligence and mobile applications, with a significant focus on the mobile health (mHealth) sector. Through its ALife Health division, the company developed digital solutions for chronic disease management, most notably the GlucoGuide application for diabetes monitoring. The company's technology utilized AI-driven virtual assistants to provide personalized health coaching and data tracking for patients. Although a pioneer in the integration of AI and mobile technology for healthcare, the company's operations have significantly diminished, and it is no longer a major player in the life sciences industry.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Artificial Life.